Blog

This blog outlines the evidence and the evidence narrative needed to achieve widespread clinical adoption and reimbursement coverage for new medical devices from a private insurer’s perspective. 

Financial Challenges – In this thirteenth blog in the series, Mark Carol, MD, a senior consultant at the Foundation, addresses the pitfalls that new companies face in securing funding. He discusses the different stages of raising capital and how the timing and terms are crucial to a company’s success.

Cybersecurity – In this twelfth blog in the series, Mark Carol, MD, a senior consultant at the Foundation, addresses the increasing concerns about medical devices in a connected world. He discusses steps the FDA has taken to mitigate cybersecurity issues and how manufacturers and hospitals can avoid a data breach.

The Foundation’s Cancer Immunotherapy Program was established in 2015, and since then, the field of focused ultrasound immuno-oncology has grown rapidly. This blog addresses the Foundation’s efforts to assess and accelerate this promising field of study.